Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-010226
Filing Date
2021-02-12
Accepted
2021-02-12 17:12:23
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 5072
  Complete submission text file 0001209191-21-010226.txt   6710
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVE 29TH FL NEW YORK NY 10106
Business Address
ELMS STEVE (Reporting) CIK: 0001250195 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37939 | Film No.: 21629444